What is ANI Pharmaceuticals's cash ratio?

ANI Pharmaceuticals (ANIP) reported cash ratio of 1.3× in Q1 2026.

How has ANI Pharmaceuticals's cash ratio changed year-over-year?

ANI Pharmaceuticals's cash ratio increased by 75.0% year-over-year, from 0.7× to 1.3×.

What is the long-term trend for ANI Pharmaceuticals's cash ratio?

Over 5 years (2020 to 2025), ANI Pharmaceuticals's cash ratio has grown at a 59.3% compound annual growth rate (CAGR), from 0.1× to 1×.

What does cash ratio mean?

Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.

ANI Pharmaceuticals ANIP Cash ratio

Cash ratio at other companies

Amneal Pharmaceuticals, Inc.AMRX

0.3×+0.2×

ViatrisVTRS

0.3×+0.1×

AnaptysBio, Inc.ANAB

6×+3.7×

ALN

Alnylam PharmaceuticalsALNY

1.3×+0.3×

Aurinia PharmaceuticalsAUPH

0.5×-0.5×

AmgenAMGN

0×0.0×

Other financials

Income statement

See full

Revenue$237.5M+20.5%

Gross profit$143.9M+16.0%

Operating income$38.9M+48.5%

Net income$29.5M+88.1%

EPS (diluted)$1.28+85.5%

Balance sheet

See full

Cash & equivalents$311.2M+108%

Total debt$305.3M-3.5%

Total equity$562.3M+34.3%

Total assets$1.4B+10.0%

Cash flow

See full

Operating cash flow$58.4M+66.8%

CapEx$6.1M+146%

Free cash flow$52.3M+60.8%

Valuation

See full

Market cap$1.89B+18.3%

Enterprise value$1.88B+5.8%

P/E20.5×—

P/S2×-0.3×

Profitability

See full

Gross margin60.8%+1.5pp

Operating margin13.4%—

Net margin10%+8.1pp

FCF margin20.7%+10.8pp

Returns & leverage

See full

Return on equity18.8%+15.6pp

Debt / equity0.5×-0.2×

Current ratio3.1×+0.5×

Where this comes from

Calculated from ANI Pharmaceuticals’s reported figures.

cash and equivalents/total current liabilities=1.3×

Based on the most recent quarter.

The official record: ANI Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about ANI Pharmaceuticals's cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ANI Pharmaceuticals's cash ratio?: ANI Pharmaceuticals (ANIP) reported cash ratio of 1.3× in Q1 2026.
How has ANI Pharmaceuticals's cash ratio changed year-over-year?: ANI Pharmaceuticals's cash ratio increased by 75.0% year-over-year, from 0.7× to 1.3×.
What is the long-term trend for ANI Pharmaceuticals's cash ratio?: Over 5 years (2020 to 2025), ANI Pharmaceuticals's cash ratio has grown at a 59.3% compound annual growth rate (CAGR), from 0.1× to 1×.
What does cash ratio mean?: Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.